STOCK TITAN

Ascend Wellness reports $35.5M Ohio asset purchase deal

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Ascend Wellness Holdings, Inc. reported that its wholly owned subsidiary Ohio Patient Access, LLC (OPA), together with a third-party entity to which the company provides financing and support services (the Retail Buyer), agreed to purchase a cultivation facility and five Ohio dispensaries for $35,500,000 in total cash consideration. OPA agreed to purchase the cultivation facility and one dispensary in Akron; the Retail Buyer agreed to purchase the other four dispensaries.

The payment schedule includes a $3,550,000 up-front deposit, $4,072,500 paid when the parties enter into effective Management Services Agreements (MSAs), $15,150,000 on the closing date, and payments of $6,226,250 and $6,501,250 on the 12- and 18-month anniversaries of closing. The MSAs are subject to regulatory approval. The transaction remains subject to customary closing conditions, including receipt of all required regulatory approvals.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Total cash consideration $35,500,000 Stated consideration for the Ohio assets
Up-front deposit $3,550,000 Paid as an up-front deposit
MSA-linked payment $4,072,500 Paid when the parties enter into effective MSAs, which are subject to regulatory approval
Closing-date payment $15,150,000 Paid on the closing date
12-month payment $6,226,250 Payable on the 12-month anniversary of closing
18-month payment $6,501,250 Payable on the 18-month anniversary of closing
Ohio dispensaries 5 dispensaries Included in the assets the Selling Parties agreed to sell
Cultivation facility 1 facility Included in the assets the Selling Parties agreed to sell
asset purchase agreement technical
"entered into an asset purchase agreement"
An asset purchase agreement is a legal contract in which a buyer agrees to buy specific assets and contracts of a business rather than buying the company’s stock or ownership. It matters to investors because it determines exactly what is being bought and what liabilities stay behind — like buying the furniture and equipment from a store but not the building or past debts — which affects the deal’s value, taxes and future risk exposure.
Management Services Agreements technical
"effective Management Services Agreements (MSAs)"
customary closing conditions technical
"subject to customary closing conditions"
"Customary closing conditions" are standard rules or checks that must be met before a business deal can be finalized, like making sure all paperwork is in order or that certain approvals are obtained. They matter because they help protect both parties, ensuring everything is in place and reducing the risk of surprises or problems after the deal is closed.
inventory and cash adjustments financial
"customary representations, warranties, covenants, inventory and cash adjustments"
indemnification provisions technical
"indemnification provisions subject to certain limitations"
Contract clauses that require one party to pay for losses, damages, or legal costs the other party suffers because of certain events or claims. They act like a contractual “safety net” or insurance: if a specified problem happens, the indemnifying party agrees to cover the financial harm. Investors care because these provisions shift potential liabilities and future cash outflows between parties, affecting a company’s risk profile and possible financial exposure.
regulatory approvals regulatory
"receipt of all required regulatory approvals"
Regulatory approvals are official permissions from government agencies that a company needs before launching a new product, service, or business activity. They matter because without this approval, the company might not be allowed to operate legally or sell its products, similar to how a driver needs a license to legally drive a car.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much is AAWH's Ohio asset purchase agreement?

Total cash consideration is $35,500,000. The schedule includes a $3,550,000 up-front deposit, $4,072,500 when effective MSAs are entered into, $15,150,000 on the closing date, and payments of $6,226,250 and $6,501,250 on the 12- and 18-month anniversaries of closing. The MSAs are subject to regulatory approval.

What assets will AAWH's subsidiary and the other buyer purchase in Ohio?

OPA agreed to purchase the cultivation facility and one Akron dispensary. The Retail Buyer, a third-party entity to which Ascend Wellness Holdings provides financing and support services, agreed to purchase the other four Ohio dispensaries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false000175639000017563902026-11-202026-11-20


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
FORM 8-K
__________________________
CURRENT REPORT
Pursuant to Section 13 OR 15(D) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 20, 2026
__________________________
ASCEND WELLNESS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

Delaware333-25480083-0602006
(State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
174 NJ-17
Rochelle Park, NJ 07662
(Address of principal executive offices)
(646) 661-7600
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below).

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 8.01.    Other Events.
Ohio Patient Access, LLC (“OPA”), an Ohio limited liability company and a wholly owned subsidiary of Ascend Wellness Holdings, Inc. (the “Company”), entered into an asset purchase agreement (the “Agreement”), by and among OPA, a third party entity to which the Company provides financing and support services (the “Retail Buyer” and, together with OPA, the “Purchasers”), on the one hand, and Greenleaf Apothecaries, LLC (“Apothecaries”), Greenleaf Gardens LLC, an Ohio limited liability company (“Gardens”), Greenleaf Therapeutics, LLC, an Ohio limited liability company (“Therapeutics”), and High Street Capital Partners, LLC, a Delaware limited liability company (“High Street,” and together with each of Apothecaries, Gardens, and Therapeutics, each a “Seller” and collectively the “Selling Parties”), on the other hand.
Pursuant to the terms of the Agreement, the Selling Parties agreed to sell to the Purchasers a cultivation facility and five dispensaries Ohio. Total stated consideration per the Agreement consists of $35,500,000 of cash consideration, with $3,550,000 paid as an up-front deposit, $4,072,500 paid on the date the parties enter into effective Management Services Agreements (“MSAs”) providing for management of the assets acquired by the respective party prior to closing (which MSAs are subject to regulatory approval), $15,150,000 on the closing date, $6,226,250 payable on the 12-month anniversary of the closing date, and $6,501,250 payable on the 18-month anniversary of the closing date. OPA agreed to purchase the cultivation facility and one dispensary in Akron, Ohio, and the Retail Buyer agreed to purchase the other four dispensaries.
The Agreement contains customary representations, warranties, covenants, inventory and cash adjustments, and indemnification provisions subject to certain limitations. The transaction remains subject to customary closing conditions, including receipt of all required regulatory approvals.
Item 9.01.    Financial Statements and Exhibits.
(d)     Exhibits.
Exhibit No.Exhibit Description
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

2


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Ascend Wellness Holdings, Inc.
November 20, 2026/s/ Roman Nemchenko
Roman Nemchenko
Chief Financial Officer
(Principal Financial Officer)
3

Filing Exhibits & Attachments

4 documents

Keep reading